• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OCN
Click for more information
0.00% 3.1¢

OCEANA LITHIUM LIMITED - Charts / Financials

Market Cap $2.557M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Oceana Lithium Ltd is an Australia-based mineral exploration and development company. The... Oceana Lithium Ltd is an Australia-based mineral exploration and development company. The Company is focused on the discovery and delineation of lithium mineral resources in two mining-friendly jurisdictions, the state of Ceara, Brazil, and the Northern Territory, Australia. The Company's projects include Solonopole Lithium Project and the Napperby Lithium project. The Solonopole lithium project, located in Ceara State, northeastern Brazil, consists of approximately eight mining permits covering approximately 114 square kilometers (Km2). The Napperby lithium project consists of a granted exploration license (EL32836) covering an area of approximately 650km2 and an exploration license application (ELA32841) covering an area of more than 512km2. The Napperby lithium project is located within the Northern Arunta pegmatite province near the settlement of Ti Tree, approximately 250km northwest of Alice Springs and 250km south of Tennant Creek.More

refresh Created with Sketch. REFRESH
Last update - 13.21pm 02/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 2.7¢ 20000   2 3.1¢ 31147

Data source: Refinitiv

(20min delay)
Last
3.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $2.557M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 20000 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 31147 2
View Market Depth
Last trade - 12.59pm 02/10/2024 (20 minute delay) ?
Last
3.0¢ 		  Change
0.000 ( 3.23 %)
Open High Low Volume
3.0¢ 3.0¢ 3.0¢ 16500
Last updated 13.21pm 02/10/2024 ?

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.